+Search query
-Structure paper
Title | BRD9 degraders as chemosensitizers in acute leukemia and multiple myeloma. |
---|---|
Journal, issue, pages | Blood Cancer J, Vol. 12, Page 110-110, Year 2022 |
Publish date | Jun 21, 2022 (structure data deposition date) |
Authors | Weisberg, E. / Chowdhury, B. / Meng, C. / Case, A.E. / Ni, W. / Garg, S. / Sattler, M. / Azab, A.K. / Sun, J. / Muz, B. ...Weisberg, E. / Chowdhury, B. / Meng, C. / Case, A.E. / Ni, W. / Garg, S. / Sattler, M. / Azab, A.K. / Sun, J. / Muz, B. / Sanchez, D. / Toure, A. / Stone, R.M. / Galinsky, I. / Winer, E. / Gleim, S. / Gkountela, S. / Kedves, A. / Harrington, E. / Abrams, T. / Zoller, T. / Vaupel, A. / Manley, P. / Faller, M. / Chung, B. / Chen, X. / Busenhart, P. / Stephan, C. / Calkins, K. / Bonenfant, D. / Thoma, C.R. / Forrester, W. / Griffin, J.D. |
External links | Blood Cancer J / PubMed:35853853 |
Methods | X-ray diffraction |
Resolution | 1.76 Å |
Structure data | PDB-8a7i: |
Chemicals | ChemComp-L8L: ChemComp-HOH: |
Source |
|
Keywords | TRANSCRIPTION / Bromodomain / BRD9 / inhibitor |